A new study implicates serotonin 2c receptors with metabolic side effects caused by a common class of antipsychotic medications.
Study reveals a link between people with depression who are prescribed newer antipsychotic medications and higher mortality risk.
During memory tasks, people with psychosis have different patterns of activity in the prefrontal and mediotemporal brain areas compared to those without the disorder. When exposed to cannabidiol (CBD), the activity of the brain areas became more like those seen in the controls for people with psychosis. Patients reported a decrease in symptoms of psychosis following one dose of CBD. Researchers stress that no definitive conclusions could be made about the effectiveness of CBD use over a sustained period.
Typical interventions for schizophrenia do not improve long-term outcomes, even when administered early, a new study reports.
A new study reports many people with intellectual disabilities are being prescribed antipsychotic medications even though they have no record of mental illness.
Researchers provide possible new insights into psychiatric disorders such as schizophrenia.
While England has only seen a moderate rise in people being diagnosed with psychosis in recent years, prescription rates for antipsychotic medications have doubled.
People with Alzheimer's disease who use antipsychotic medications have a 29% higher risk of head injury, and a 22% increased risk of TBI compared to those with the neurodegenerative disease who do not use the medications.
Researchers say 80% of people taking antipsychotics to manage schizophrenia or bipolar disorder experience considerable weight gain. Some patients report up to 33kg of weight gain following taking antipsychotic medications. A new study aims to explore ways of managing weight gain for patients taking antipsychotics.
According to a new study, antipsychotic medications could increase the risk of death in patients with Parkinson's disease psychosis.
Sustained use of the antipsychotic olanzapine resulted in potentially adverse alterations in brain structure, specifically cortical thinning.
A link has been identified between psychosis and a genetic change that alters the immune system in the brain. Researchers found people with psychosis associated with bipolar disorder had decreased expression of GRK3. This led to an increased amount of kynurenic acid in the brain.
